VantAI, a leader in ML technologies for drug discovery, is excited to announce the appointment of Dr. Michael Bronstein as Chief Scientist in Residence. Bronstein is the DeepMind Professor of AI at the University of Oxford and an internationally acclaimed scientist with a track record of excellence in geometric deep learning. He will play a pivotal role in helping VantAI unlock the potential of induced proximity as a novel and transformative therapeutic modality. This appointment underscores VantAI’s commitment to innovation in the realm of artificial intelligence (AI) and drug discovery.